PDE4D and metabolic dysfunction-associated steatotic liver disease: Given that a high-fat diet (HFD) has been well documented to be a causative factor for NAFLD and renal dysfunction [17–19], whether roflumilast can ameliorate renal injury induced by a HFD and how hepatic PDE4D mediates NAFLD-associated CKD in HFD mice remain unknown.